The U.S. Food and Drug Administration (FDA) recently updated its constituents about the agency’s ongoing Cyclospora cayetanensis prevention and research efforts. In 2021, FDA released its Cyclospora Prevention, Response and Research Action Plan. The action plan was developed by the agency’s Cyclospora Task Force and details FDA’s strategy for reducing the public health burden of foodborne cyclosporiasis in the U.S. It also defines the agency’s priorities for Cyclospora food safety research and supports ongoing efforts to combat foodborne illness in alignment with FDA’s New Era of Smarter Food Safety initiative.
Since releasing the Cyclospora action plan, FDA has made progress on several goals. The agency’s activities related to the Cyclospora action plan include: